Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
about
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarrayMolecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic CancerTargeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasCell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.Increased cyclin D1 expression in cancer of the ampulla of Vater: relevance to nuclear beta catenin accumulation and k-ras gene mutationTailoring to RB: tumour suppressor status and therapeutic response.Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNAUbiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibilityMolecular characteristics of pancreatic ductal adenocarcinomaCancer stem-like cells enriched in Panc-1 spheres possess increased migration ability and resistance to gemcitabine.Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions.Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancerCyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.Overexpression of Caspase-1 in adenocarcinoma of pancreas and chronic pancreatitis.Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cellsExpression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.Molecular genetics of pancreatic intraepithelial neoplasia.Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs)Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients.Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomasInhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.Specific down-regulation of an engineered human cyclin D1 promoter by a novel DNA-binding ligand in intact cells.The radiation-sensitizing effect of flavopiridol in the esophageal cancer cell line Eca109.Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer.Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growthHelicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells.Antiaging Effect of Inula britannica on Aging Mouse Model Induced by D-Galactose.Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth.Characterizing DNA methylation patterns in pancreatic cancer genome.Cyclin D1 and human neoplasia
P2860
Q24657451-4CE69927-66F2-4A28-8188-FC71903E192EQ26765241-EB3A3763-1793-4EDC-85C3-00F84655349BQ26827580-EA6D1272-214A-430B-A874-71B5CF69639DQ28567562-A4705D38-5F6A-451C-8843-039A36734E50Q33822845-20A56F6C-5B2B-427D-8F50-4D3CAD6F769BQ33828576-D96270B1-3536-422E-9962-8E647D57ABE4Q33919283-C15FE47D-7120-4454-A1E2-21F9052C15F6Q34040108-4563DCDF-DF8F-499C-AA8F-331DFE1E2CD8Q34167898-154BC774-5907-4E4A-B22A-AA08DA615FA6Q34346963-0A8542AE-58E8-47AB-9FC4-DAACD8A03793Q34745252-9DA47050-AE93-4864-8F1D-4787B78360E0Q35036055-21C6D1F6-8445-4276-B313-76DDAA0C22D2Q35186531-3ADB1E07-D63F-4688-9E67-DA3E9019065EQ35594679-64D82475-3B37-4260-95F3-03C4B0DB07B4Q35653762-E75219DE-CF73-4FDB-A169-3975939F453FQ35745372-69AD0F13-D7BD-4047-BE6D-89E4257B5B25Q35809860-BA305713-A789-4041-BA3F-4A0BAE83B348Q36170317-87853A39-2EF1-405E-9C5C-90DA39AF6B81Q36180587-D5CEED81-F005-431C-9512-F308647F03ACQ36512280-739331E5-C401-4D17-918C-87CF1779CA1BQ36641066-7ACBEE66-2EF6-4440-B153-235E8CA3F250Q36781251-D8C9354B-DBBE-45F6-A533-4484B90B7081Q36829524-34BEF7DF-6D73-4912-B674-7CEDA2EC5E62Q37088011-DAF044DD-EA9D-4B2D-BCF9-D0ABEC1C6B75Q37135253-67123352-1507-4442-A72D-7F648F5716ABQ37225394-B3698EE0-E2E2-4632-B76A-6F24A6E813BDQ37377431-D20AB4AB-6B96-4661-9894-61D92A066EC2Q37586623-2F5CFD75-337A-46FD-B612-420D09BCD026Q38369468-A1BF600C-6A15-41F0-9027-FBA2450738F6Q38663358-8E096DE3-49E4-42F3-8F3F-01D16C57AC9AQ38668687-D91731CC-0F15-40F0-9EC3-7AC07BB159A3Q39129076-7147BD60-A07D-4FF0-9554-4205B2CEB383Q39226835-C7D50682-C8AD-4183-9BF6-63139734DA01Q39498818-21CD88A6-F2CB-426C-9F73-7F321592DD60Q39520921-D667DB9D-83C8-43AD-83A5-CDE7BC335098Q39616204-8D822B84-4A2A-42FB-B77E-9EDBC5D53D4AQ39706220-636BCF84-F878-448F-B3E9-6AFC808E352CQ39784275-5CDE0EA3-FDFD-4C6F-A49D-833DB1FBE7B9Q39842549-43620FB0-D01B-486A-9A3A-8FAC2AA4BA2DQ40794379-1DB27658-A80A-4D5B-BFC6-C14E8419ABA4
P2860
Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Overexpression of cyclin D1 in ...... associated with poor prognosis
@ast
Overexpression of cyclin D1 in ...... associated with poor prognosis
@en
Overexpression of cyclin D1 in ...... associated with poor prognosis
@nl
type
label
Overexpression of cyclin D1 in ...... associated with poor prognosis
@ast
Overexpression of cyclin D1 in ...... associated with poor prognosis
@en
Overexpression of cyclin D1 in ...... associated with poor prognosis
@nl
prefLabel
Overexpression of cyclin D1 in ...... associated with poor prognosis
@ast
Overexpression of cyclin D1 in ...... associated with poor prognosis
@en
Overexpression of cyclin D1 in ...... associated with poor prognosis
@nl
P2093
P3181
P1433
P1476
Overexpression of cyclin D1 in ...... associated with poor prognosis
@en
P2093
F Gansauge
M Ramadani
S Gansauge
P304
P3181
P356
10.1007/978-3-642-60717-2_31
P407
P577
1997-05-01T00:00:00Z